TNF Pharmaceuticals (TNFA) Competitors $1.22 -0.01 (-0.80%) (As of 01:59 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsSEC FilingsTrends TNFA vs. AWH, TRIB, VRAX, CDIO, BMRA, MYMD, NAVB, IDXX, LNTH, and NEOGShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Aspira Women's Health (AWH), Trinity Biotech (TRIB), Virax Biolabs Group (VRAX), Cardio Diagnostics (CDIO), Biomerica (BMRA), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), Lantheus (LNTH), and Neogen (NEOG). These companies are all part of the "diagnostic substances" industry. TNF Pharmaceuticals vs. Aspira Women's Health Trinity Biotech Virax Biolabs Group Cardio Diagnostics Biomerica MyMD Pharmaceuticals Navidea Biopharmaceuticals IDEXX Laboratories Lantheus Neogen TNF Pharmaceuticals (NASDAQ:TNFA) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, community ranking, media sentiment, risk, dividends and valuation. Do insiders & institutionals have more ownership in TNFA or AWH? 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are owned by institutional investors. 1.2% of TNF Pharmaceuticals shares are owned by company insiders. Comparatively, 4.3% of Aspira Women's Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to TNFA or AWH? In the previous week, Aspira Women's Health had 6 more articles in the media than TNF Pharmaceuticals. MarketBeat recorded 6 mentions for Aspira Women's Health and 0 mentions for TNF Pharmaceuticals. Aspira Women's Health's average media sentiment score of 0.26 beat TNF Pharmaceuticals' score of 0.00 indicating that Aspira Women's Health is being referred to more favorably in the news media. Company Overall Sentiment TNF Pharmaceuticals Neutral Aspira Women's Health Neutral Which has more risk & volatility, TNFA or AWH? TNF Pharmaceuticals has a beta of 2.17, meaning that its stock price is 117% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Do analysts recommend TNFA or AWH? Aspira Women's Health has a consensus target price of $4.40, indicating a potential upside of 494.59%. Given Aspira Women's Health's stronger consensus rating and higher probable upside, analysts plainly believe Aspira Women's Health is more favorable than TNF Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TNF Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aspira Women's Health 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community favor TNFA or AWH? Aspira Women's Health received 14 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTNF PharmaceuticalsN/AN/AAspira Women's HealthOutperform Votes1420.00% Underperform Votes5680.00% Is TNFA or AWH more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets TNF PharmaceuticalsN/A -180.71% -84.27% Aspira Women's Health -165.07%N/A -255.28% Which has preferable valuation and earnings, TNFA or AWH? TNF Pharmaceuticals has higher earnings, but lower revenue than Aspira Women's Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTNF PharmaceuticalsN/AN/A-$4MN/AN/AAspira Women's Health$9.15M1.30-$16.69M-$1.20-0.62 SummaryAspira Women's Health beats TNF Pharmaceuticals on 10 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.37M$2.23B$5.10B$8.84BDividend YieldN/A0.75%5.04%4.07%P/E RatioN/A3.9195.1214.22Price / SalesN/A42.281,217.3088.42Price / CashN/A14.8239.4936.27Price / Book0.203.106.976.37Net Income-$4M$29.98M$118.73M$225.56M7 Day Performance0.02%-1.06%-1.22%-0.02%1 Month Performance-25.60%-9.76%-3.07%2.04%1 Year PerformanceN/A-14.64%32.52%28.00% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$1.22-0.8%N/AN/A$3.37MN/A0.006AWHAspira Women's Health1.6792 of 5 stars$0.74+1.4%$4.40+494.6%-78.5%$11.88M$9.15M-0.64110Analyst ForecastTRIBTrinity Biotech1.8381 of 5 stars$1.28-1.5%N/A-33.5%$9.75M$56.83M-0.58480VRAXVirax Biolabs Group0.2701 of 5 stars$1.91+1.6%N/A-24.8%$6.17M$160,000.000.005CDIOCardio Diagnostics2.1281 of 5 stars$0.25+2.4%$2.00+700.0%-89.0%$5.99M$20,000.000.007BMRABiomerica0.2078 of 5 stars$0.32-1.9%N/A-64.4%$5.35M$5.41M-0.8860News CoverageGap DownMYMDMyMD PharmaceuticalsN/A$1.23+7.0%N/A-87.3%$2.92MN/A0.009NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-98.3%$100,000.00$70,000.000.0010IDXXIDEXX Laboratories4.8703 of 5 stars$414.75-0.9%$552.38+33.2%-11.5%$33.96B$3.66B40.3711,000Positive NewsGap DownLNTHLantheus4.601 of 5 stars$87.91+1.7%$122.50+39.3%+25.1%$6.11B$1.30B14.64834Positive NewsNEOGNeogen2.1658 of 5 stars$14.91+0.1%$17.50+17.4%-8.5%$3.23B$924.22M-135.452,640 Related Companies and Tools Related Companies Aspira Women's Health Alternatives Trinity Biotech Alternatives Virax Biolabs Group Alternatives Cardio Diagnostics Alternatives Biomerica Alternatives MyMD Pharmaceuticals Alternatives Navidea Biopharmaceuticals Alternatives IDEXX Laboratories Alternatives Lantheus Alternatives Neogen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNFA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.